Collection's Items (Sorted by Submit Date in Descending order): 741 to 760 of 773
Issue Date | Title | Author(s) |
2010-11 | Design, synthesis and structure–activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression | Mahesh, R. |
2014-07 | Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models | Mahesh, R. |
2015-01 | QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice | Mahesh, R. |
2006-05 | Synthesis and biological evaluation of a novel structural type of serotonin 5-HT3 receptor antagonists | Mahesh, R. |
2014-06 | Ondansetron attenuates depression co-morbid with obesity in obese mice subjected to chronic unpredictable mild stress; an approach using behavioral battery tests | Mahesh, R. |
2014-08 | Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy | Mahesh, R. |
2015-09 | Ondansetron attenuates co-morbid depression and anxiety associated with obesity by inhibiting the biochemical alterations and improving serotonergic neurotransmission | Mahesh, R. |
2015-05 | Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: Involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense system | Mahesh, R. |
2014-03 | Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice | Mahesh, R. |
2015-10 | Mechanisms linking depression co-morbid with obesity: An approach for serotonergic type 3 receptor antagonist as novel therapeutic intervention | Mahesh, R. |
2016-06 | Pioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice | Mahesh, R. |
2004-10 | Microwave assisted synthesis of 2-(4-substituted piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile as a new class of serotonin 5-HT3 receptor antagonists | Mahesh, R. |
2007-12 | Potential antidepressants: Pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models | Mahesh, R. |
2014-09 | 5HT3 receptor antagonist (ondansetron) reverses depressive behavior evoked by chronic unpredictable stress in mice: Modulation of hypothalamic–pituitary–adrenocortical and brain serotonergic system | Mahesh, R. |
2015-05 | Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents | Mahesh, R. |
2011-02 | Discovery of new anti-depressants from structurally novel 5-HT3 receptor antagonists: Design, synthesis and pharmacological evaluation of 3-ethoxyquinoxalin-2-carboxamides | Mahesh, R. |
2010-02 | Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery | Mahesh, R. |
2016-05 | 5HT3 receptors: Target for new antidepressant drugs | Mahesh, R. |
2010-12 | Effect of acute and chronic treatment with QCF-3 (4-benzylpiperazin-1-yl) (quinoxalin-2-yl) methanone, a novel 5-HT3 receptor antagonist, in animal models of depression | Mahesh, R.; Yadav, Shushil K. |
2013-11 | Etazolate rescues behavioral deficits in chronic unpredictable mild stress model: Modulation of hypothalamic–pituitary–adrenal axis activity and brain-derived neurotrophic factor level | Mahesh, R. |
Collection's Items (Sorted by Submit Date in Descending order): 741 to 760 of 773